9 July 2026 ANCA-associated vasculitis FDA Pharmaceuticals Avacopan trial retracted as regulators diverge
9 July 2026 ANCA-associated vasculitis Pharmaceuticals CSL issues open letter as EU moves to revoke avacopan approval
9 July 2026 Interstitial Lung Disease Pharmaceuticals Rheumatoid Arthritis Methotrexate comes out best in RA-ILD analysis
16 April 2026 Osteoarthritis Pharmaceuticals Research Rheumatology Early evidence for targeting neurotrophins in osteoarthritis
2 April 2026 Clinical research Pharmaceuticals Polymyalgia Rheumatica Secukinumab boosts remission in PMR
